Editorial Board

Suresh K. Alahari, PhD, FAAS, FASCB, Drexel University, United States of America
Cristine Alves da Costa, PhD, Institut de Pharmacology Moléculaire et Cellulaire, France
Albert S. Baldwin, PhD, University of North Caroliina at Chapel Hill, United States of America
Jiri Bartek MD, PhD, Dr.h.c. mult., Danish Cancer Institute, Denmark
Amer A. Beg, PhD, Moffitt Cancer Center, United States of America 
Francois-Clement Bidard, MD, PhD, Institut Curie and Versailles/Paris-Saclay University, France
Gavin Bowen-Metcalf, PhD, MRes, DIC, PG Cert, BSc Hons, FHEA, Anglia Ruskin University, United Kingdom
Cameron Bracken, PhD, University of South Australia, Australia
Stephen K. Burley, MD, DPhil, Rutgers University, United States of America
Huarong Chen, PhD, The Chinese University of Hong Kong, China
Y. Eugene Chinn, PhD, Binzhou Medical University, China
J. Alan Diehl, PhD, Case Western Reserve University, United States of America
George Dranitsaris, PhD, Syracuse University, United States of America
Christopher A. French, MD, Brigham and Women’s Hospital/Harvard Medical School, United States of America
Irwin H. Gelman, MS, MPh, PhD, Roswell Park Comprehensive Cancer Center, United States of America
Philip A. Gregory, PhD, University of South Australia, Australia
Richard P. Grose, PhD, Queen Mary University of London, United Kingdom
Weidong Han, MD, Chinese People Liberation Army General Hospital, China
Hannelore V. Heemers, PhD, Cleveland Clinic, United States of America
Daniel Herranz, PharmD, PhD, Rutgers Cancer Institute of New Jersey, United States of America
Rakesh Kumar, PhD, Himalayan Institute of Medical Sciences, India
Soo-Chin Lee, MD, FAMS, FRCP, National University Cancer Institute, Singapore
Heinz Josef Lenz, MD, FACP, University of Southern California, United States of America
Jonathan D. Licht, MD, The University of Florida, United States of America
Daniel B. Longley, PhD, Queen's University Belfast, United Kingdom
David Lyden, MD, PhD, Weill Cornell Medicine, United States of America
Nupam Mahajan, PhD, Washington University in St. Louis, United States of America
Gerry Melino,  MD, PhD, Dr Sci, University Tor Vergata, Italy
Sara Meyer, PhD, Thomas Jefferson University, United States of America
Gareth J. Miles, PhD, University of Leicester, United Kingdom
Siddhartha Mukherjee, MD, Dphil, Columbia University, United States of America
Salvatore Papa, PhD, University of Leeds, United Kingdom
Ling Peng, MD, PhD, TCRCure Biopharma Ltd, China
Jonathan R. Pollack, MD, PhD, Stanford University, United States of America
Carol Prives, PhD, Columbia University, United States of America
Nidhi Sahni, PhD, University of Texas MD Anderson Cancer Center, United States of America
Colinda L.G.J. Scheele, PhD, VIB-KU Leuven Center for Cancer Biology, Belgium
Marius Sudol, PhD, Icahn School of Medicine at Mount Sinai, United States of America
Kate D. Sutherland, BSc (Hons), PhD, The Walter and Eliza Hall Institute of Medical Research, Australia
David A. Tuveson, MD, PhD, FAACR, Cold Spring Harbor Laboratory, United States of America
Mark D. Vincent, MD, FRCPC, MRCPUK, University of Western Ontario and London Regional Cancer Program, Canada
Ying-Jie Wang, PhD, Zhejiang University, China
Janindra Warusavitarne, BMed, FRACS, PhD, FEBSQ(colo), St Mark’s Hospital and Imperial College London, United Kingdom
Keith T. Wilson, MD, Vanderbilt University Medical Center, United States of America
Jedd D. Wolchok, MD, PhD, FAACR, FASCO, Weill Cornell Medical Center, United States of America
Chi Chun Wong, PhD, The Chinese University of Hong Kong, China
William K.K. Wu, PhD, FRCPath, FRCP, The Chinese University of Hong Kong, China
Gerard P. Zambetti, PhD, St. Jude Children’s Research Hospital, United States of America
Changsheng (Jonathan) Zhao, MD, Emory University, United States of America